<DOC>
	<DOC>NCT01075516</DOC>
	<brief_summary>The purpose of the study is to define the economic value of implantable cardioverter defibrillator (ICD) remote monitoring for hospitals, third payers and patients in Italy. Aims of the study are to develop a hospital cost minimization analysis and a cost effectiveness analysis based on direct estimation of costs and quality of life deriving from remote follow up (performed with Merlin@home and Merlin.net) compared to standard follow up in the management of ICD implanted patients.</brief_summary>
	<brief_title>Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Defibrillator (ICD) Patients</brief_title>
	<detailed_description>TARIFF is a prospective observational study aimed to measure direct, indirect costs and quality of life of all participants for the duration of the observational timeframe. Purpose of cost collecting is to include a complete set of medical services and productivity loses that could be directly affected by the different clinical FU pathway. The study consists of 2 phases: firstly standard follow up costs will be collected for 100 pts, then all costs associated to remote follow ups will be collected for other 100 patients.</detailed_description>
	<criteria>Patients already implanted with ICD Patients able to be followed in the same centre during all the study Patients with age &gt; 18 Patients able to understand and to answer to EQ5D Questionnaire Patients pregnant Patients unable to connect Merlin@home transmitters with Website Merlin.net (i.e.without telephonic analogic line or GSM/UMTS connection)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Remote Monitoring</keyword>
	<keyword>ICD patients</keyword>
	<keyword>EQ-5D questionnaire</keyword>
	<keyword>remote follow up</keyword>
</DOC>